vr-hGH

Medical Utility

  • Prediction of cardiovascular risk in men (Hazard Ratio greater than 15) for guidance of cardiovascular check-up
  • Prevention of disease: Identified risk can be counteracted with ACEi/ARB therapy – independent of blood pressure

sphingotest® vr-hGH Immunoassay

  • sphingotest® vr-hGH is an ultra sensitive assay for Human Groth Hormone (hGH), indicating the vascular risk
  • The only IVD method to determine the low fasting plasma levels in men
  • The sphingotest® vr-hGH Broschure can be downloaded here

Literature

  1. Hallengren E, Almgren P, Engström G, Hedblad B, Persson M, Suhr J, Bergmann A, Melander O. Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: the Malmö Diet and Cancer study. J Am Coll Cardiol. 2014; 64(14):1452-60. PubMed PMID: 252776167.
  2. Ng LL, Bhandari SS, Sandhu JK, Quinn PA, Squire IB, Davies JE, Struck J, Bergmann A, Jones DJ. Growth hormone for risk stratification and effects of therapy in acute myocardial infarction. Biomarkers. 2015;20(6-7):371-5. doi: 10.3109/1354750X.2015.1093031. Epub 2015 Nov 2. PubMed PMID: 26525661.

Cookie Preference

Please select an option. You can find more information about the consequences of your choice at Help. Privacy Policy | Imprint

Select an option to continue

Your selection was saved!

More information

Help

To continue, you must make a cookie selection. Below is an explanation of the different options and their meaning.

  • Accept all cookies:
    All cookies such as tracking and analytics cookies.
  • Accept first-party cookies only:
    Only cookies from this website.
  • Reject all cookies:
    No cookies except for those necessary for technical reasons are set. Borlabs Cookie already set a necessary cookie.

You can change your cookie setting here anytime: Privacy Policy. Imprint

Back

Top